Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-cash Items (2018 - 2025)

Assembly Biosciences (ASMB) has 7 years of Non-cash Items data on record, last reported at $1.4 million in Q4 2024.

  • For Q4 2024, Non-cash Items rose 138200.0% year-over-year to $1.4 million; the TTM value through Dec 2024 reached $1.4 million, up 138200.0%, while the annual FY2024 figure was $1.4 million, 138200.0% up from the prior year.
  • Non-cash Items reached $1.4 million in Q4 2024 per ASMB's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $63.2 million in Q2 2020 and bottomed at $1000.0 in Q3 2022.
  • Average Non-cash Items over 5 years is $8.0 million, with a median of $1.4 million recorded in 2024.
  • Peak YoY movement for Non-cash Items: plummeted 99.83% in 2022, then skyrocketed 138200.0% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $1.9 million in 2020, then tumbled by 97.14% to $53000.0 in 2021, then plummeted by 98.11% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 138200.0% to $1.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $1.4 million in Q4 2024, $1000.0 in Q4 2023, and $1000.0 in Q3 2022.